BAX
$81.09
Baxter International
($.36)
(.44%)
BAX
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.73
Revenue:  $2.83 Bil
Thursday
Oct 29
7:15 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, July 30, 2020

What do you expect when BAX reports earnings?
Beat
Meet
Miss

Where is BAX's stock price going from here?
Up
Flat
Down
Stock chart of BAX
Analysts
Summary of analysts' recommendations for BAX
Score
Grade
Pivots
Resistance
$82.82
$82.38
$81.73

$81.29

Support
$80.64
$80.20
$79.55
Tweet
Growth
Description
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Peers
StrykerBoston ScientificBecton, DickinsonAbbottWatersIntegra LifeSciences HoldingsCardiovascular SystemsTeleflex3MHill-Rom Holdings